Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001862420 | SCV002164083 | uncertain significance | PRPH2-related disorder | 2021-12-08 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 829860). This variant has not been reported in the literature in individuals affected with PRPH2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change affects an acceptor splice site in intron 2 of the PRPH2 gene. While this variant is not anticipated to result in nonsense mediated decay, it likely alters RNA splicing and results in a disrupted protein product. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Bioscientia Institut fuer Medizinische Diagnostik Gmb |
RCV001029800 | SCV001192579 | likely pathogenic | Adult-onset foveomacular vitelliform dystrophy | 2019-06-05 | no assertion criteria provided | clinical testing |